Market growth will be driven by combination therapies, longer-acting formulations, and broader treatment applications, making India a key expansion ground
Two other pharmaceutical companies have their own oral GLP-1 drugs in the works: Orforglipron: Developed by Eli Lilly, its in Phase 3 clinical trials for treating type 2 diabetes and obesity, with an expected September 2025 completion
After you stop taking Ozempic, how long does regrowth usually take
Hannon et al., 2002b
Keep the capsules in their original sealed container at controlled room temperature, dry and away from heat, light and moisture, and follow the specific storage guidance supplied with your product
Cholesterol impact represents the primary concern, with HDL cholesterol often decreasing while LDL may increase